A Aralex Aachen research explorer

Company ROR OpenAlex

Galapagos (Netherlands) Sign in to save

159 stored papers · Search its papers → · Its authors →

Papers 159

POS0676 EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY
2022 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access

3

citations
P393 Effect of filgotinib on anaemia in patients with Ulcerative Colitis in SELECTION
2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access

3

citations
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trials
2025 ERJ Open Research article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access

3

citations
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes
2026 JCI Insight article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access

3

citations
Effects of GLPG3970 on Sulfasalazine and Methotrexate Pharmacokinetics in Healthy Adults: Two Open‐Label, Phase I, Drug–Drug Interaction Studies
2024 Clinical Pharmacology & Therapeutics article Medicine Drug Transport and Resistance Mechanisms Open access

3

citations
How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
2022 Clinical Pharmacology & Therapeutics article Medicine Cardiac electrophysiology and arrhythmias Open access

3

citations
Fi-score: a novel approach to characterise protein topology and aid in drug discovery studies
2020 Journal of Biomolecular Structure and Dynamics article Biochemistry, Genetics and Molecular Biology Protein Structure and Dynamics

3

citations
In silico drug discovery for a complex immunotherapeutic target - human c-Rel protein
2021 Biophysical Chemistry article Computer Science Computational Drug Discovery Methods

3

citations
Rapid Lineage Assignment of Severe Acute Respiratory Syndrome Coronavirus 2 Cases through Automated Library Preparation, Sequencing, and Bioinformatic Analysis
2023 Journal of Molecular Diagnostics article Medicine SARS-CoV-2 detection and testing Open access

3

citations
FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS
2020 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access

3

citations
FRI0115 FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, AND HEALTH-RELATED QUALITY OF LIFE, AND REDUCED FATIGUE OVER TIME IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE METHOTREXATE-NAÏVE: RESULTS FROM THE FINCH 3 STUDY
2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies

3

citations
FRI0128 FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, HEALTH-RELATED QUALITY OF LIFE, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM THE FINCH 1 STUDY
2020 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access

3

citations
OP0126 INFECTIONS AND SERIOUS INFECTIONS IN THE FILGOTINIB RHEUMATOID ARTHRITIS PROGRAM
2021 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access

3

citations
OP35 Efficacy and safety outcomes up to ~4 years of treatment with filgotinib 200 mg among patients with Ulcerative Colitis: Results from the SELECTIONLTE study
2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access

3

citations
Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
2024 Blood conference-abstract Medicine CAR-T cell therapy research Open access

3

citations
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 MCL cohort
2025 Blood conference-abstract Medicine CAR-T cell therapy research

3

citations
P520 Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme
2023 Journal of Crohn s and Colitis article Medicine Rheumatoid Arthritis Research and Therapies Open access

2

citations
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: post hoc analysis of the phase 2b/3 SELECTION study
2024 Intestinal Research article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access

2

citations
Fi-score: a novel approach to characterise protein topology and aid in drug discovery studies
2020 bioRxiv (Cold Spring Harbor Laboratory) preprint Computer Science Computational Drug Discovery Methods Open access

2

citations
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis
2022 Rheumatology and Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access

2

citations

Most cited authors